DFX Intelligence

Data Factory

VentureFirmpe with venture activity · probableregistered_investment_adviser

Ecor1 Capital, LLC

Venture Capital

San Francisco, CA

We are a San Francisco based biotech-focused investment fund. Come forge the future of biotech with us.

This is the graph view. The full profile, with its team, deals and sources, is on Venture Capital.Open the full profile →

Search this name across graphsid dfx:vc:445071c5-b635-403c-b98a-5507d44ff9b7

Data as of Sep 17, 2026 (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built Sep 19, 2026, 9:35 AM UTC and rebuilt at most every 15 minutes.

Relationships: 21
Dated events: 2
On other graphs: 1
Observed: Sep 12, 2026 to Sep 17, 2026
54 observations

Across DFX

same identity by shared identifier, citation, or a bridge measured by hand

RIA / Wealth Managementidentity

ECOR1 CAPITAL, LLC

Registered adviser · shared crd

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Funds: 1
Vintages: 2019 to 2019
Reported GAV: $85.3Mgross asset value on Form ADV; never dry powder
Regulatory AUM: $3.4B
Funds with fundraising evidence: 0derived
Investments: 1
Portfolio companies: 1
Investments, 12m: 0
Partner-attributed: 0
People: 16
Investment professionals: 8derived
Co-investors: 0derived
LP relationships: 0
Stated sectors: biotechas stated by the firm
Latest Form D: May 8, 2020
Latest ADV filing: Mar 30, 2026
Website: ecor1cap.com

Funds

Fund	Vintage	Lifecycle	Form D sold	GAV	LPs
Ecor1 Venture Opportunity Fund, LP	2019	Mature	$5.5M	$85.3M	0

Investments

round size is never this investor's check

Company	State	Stage	Round size	Partner	Attribution	Observed
Attovia Therapeutics	n/a	Series c	$90.0M	n/a	Unknown	Apr 15, 2025

Co-investors

pairs come only from shared rounds and listings

Investor	Co-investor	Shared deals	Shared companies	Last observed	Strength
Nextech Ventures	Ecor1 Capital, LLC	1	1	Apr 15, 2025	One time
Sanofi Ventures	Ecor1 Capital, LLC	1	1	Apr 15, 2025	One time
Deep Track Capital	Ecor1 Capital, LLC	1	1	Apr 15, 2025	One time
Marshall Wace	Ecor1 Capital, LLC	1	1	Apr 15, 2025	One time
Ecor1 Capital, LLC	Cormorant Asset Management	1	1	Apr 15, 2025	One time
Ecor1 Capital, LLC	Goldman Sachs Alternatives	1	1	Apr 15, 2025	One time

Relationships

Employs (16)

→ Scott PerlenPersonCfo
factThe subject's own site
→ Whan LeePersonSENIOR Analyst
factThe subject's own site
→ Oleg NodelmanPersonFounder + Portfolio Manager
factThe subject's own site
→ Areesha SaifPersonAnalyst
factThe subject's own site
→ Basheer ZadaPersonPrincipal
factThe subject's own site
→ Caroline ChoPersonExecutive Personal Assistant
factThe subject's own site
→ Caroline StoutPersonPartner
factThe subject's own site
→ Daniel ChizhikovPersonAnalyst
factThe subject's own site
→ Daniel RodriguezPersonCounsel
factThe subject's own site
→ Maddie GehrichPersonInvestor Relations Associate
factThe subject's own site
→ Miranda FornaroPersonOperations manager
factThe subject's own site
→ Nima EmamiPersonAnalyst
factThe subject's own site
→ Oleg KhusainovPersonController
factThe subject's own site
→ Sarah MarriottPersonPartner, COO + GC
factThe subject's own site
→ Trustee Oleg NodelmanPersonManager
Nov 1, 2012 to presentfactForm ADV
→ Trustee Sarah MarriottPersonMember, Cco, Coo
Nov 1, 2012 to presentfactForm ADV

Invested in (1)

→ Attovia TherapeuticsCompanyround
Apr 15, 2025 to presentfactNews and newswire

Manages (4)

→ Ecor1 Capital Fund, L.P.FundHedge Fund
Mar 25, 2014 to presentfactForm ADV
→ Ecor1 Capital Fund Qualified, L.P.FundHedge Fund
Mar 25, 2014 to presentfactForm ADV
→ Ecor1 Special Opportunity Fund I, LPFundHedge Fund
Mar 30, 2015 to presentfactForm ADV
→ Ecor1 Venture Opportunity Fund, LPFundHedge Fund
Aug 29, 2019 to presentfactForm ADV

Dated events

1 bookkeeping events (roster, classification and holdings changes) folded below

Occurred
Mar 25, 2014
Adviser's first ADV filing
Ecor1 Capital, LLC first filed Form ADV (ERA)
Form ADVobserved 6 days ago

Show 1 bookkeeping events

Occurred
Aug 29, 2019
Ecor1 Venture Opportunity Fund, LP first reported on Form ADV by Ecor1 Capital, LLC (Hedge Fund), GAV $20,279,077

Who to call

the organisation, the role and the published line, with the filing or website that published it; revealed to signed-in accounts

The firm's published line

Revealable: 1 business phone (Form ADV), 1 website (Form ADV), 1 work email (firm website) · as of 2026-09-17

Whan Lee
SENIOR Analyst · Revealable: 1 work email (firm website)

Also named here, with no published line of their own (reach them through the firm): Scott Perlen (CFO), Oleg Nodelman (Founder + Portfolio Manager), Areesha Saif (Analyst), Basheer Zada (PRINCIPAL), Caroline Cho (Executive Personal Assistant), Caroline Stout (Partner), Daniel Chizhikov (Analyst), Daniel Rodriguez (Counsel), Maddie Gehrich (Investor Relations Associate), Miranda Fornaro (Operations manager), Nima Emami (Analyst), Oleg Khusainov (Controller).

Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan

Provenance

Graph: Venture Capital
Canonical id: dfx:vc:445071c5-b635-403c-b98a-5507d44ff9b7
First observed: Sep 12, 2026
Last observed: Sep 17, 2026 2 days ago
Source families: Federal regulator filings, Firm and issuer disclosures
3 registered feeds stand behind this record; each fact above carries its own dates and, where the publisher serves one, its document.
Resolution: Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.

Ecor1 Capital, LLC

Venture Capital

San Francisco, CA

We are a San Francisco based biotech-focused investment fund. Come forge the future of biotech with us.

This is the graph view. The full profile, with its team, deals and sources, is on Venture Capital.Open the full profile →

Search this name across graphsid dfx:vc:445071c5-b635-403c-b98a-5507d44ff9b7

Data as of Sep 17, 2026 (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built Sep 19, 2026, 9:35 AM UTC and rebuilt at most every 15 minutes.

Fund

Vintage

Lifecycle

Form D sold

GAV

LPs

Ecor1 Venture Opportunity Fund, LP

2019

Mature

$5.5M

$85.3M

Company

State

Stage

Round size

Partner

Attribution

Observed

Attovia Therapeutics

n/a

Series c

$90.0M

n/a

Unknown

Apr 15, 2025

Investor

Co-investor

Shared deals

Shared companies

Last observed

Strength

Nextech Ventures

Ecor1 Capital, LLC

Apr 15, 2025

One time

Sanofi Ventures

Ecor1 Capital, LLC

Apr 15, 2025

One time

Deep Track Capital

Ecor1 Capital, LLC

Apr 15, 2025

One time

Marshall Wace

Ecor1 Capital, LLC

Apr 15, 2025

One time

Ecor1 Capital, LLC

Cormorant Asset Management

Apr 15, 2025

One time

Ecor1 Capital, LLC

Goldman Sachs Alternatives

Apr 15, 2025

One time